Ebner Stolz advises Curaleaf Holdings, Inc. on the acquisition of a majority stake in Four 20 Pharma GmbH
The auditing and consulting firm Ebner Stolz has assisted Curaleaf Holdings, Inc. (Curaleaf) in the acquisition of a 55% stake in the German medical cannabis producer and distributor Four 20 Pharma GmbH (Four 20 Pharma) with a financial and tax due diligence. ...read more